Child advocacy and robust community-centered research

Archives of Pediatrics and Adolescent Medicine

Volumn 155, Issue 4, 2001, Pages 438-439

  Feudtner, C ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTAME; PIRACETAM; VITAMIN;

BRAIN DYSFUNCTION; CLINICAL TRIAL; COMMUNITY CARE; DOWN SYNDROME; EDITORIAL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERACTIVITY; MEDICAL RESEARCH; PEDIATRICS; PRIORITY JOURNAL; PUBLIC OPINION; RESOURCE ALLOCATION; TREATMENT INDICATION;

EID: 0035073289     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.155.4.438     Document Type: Editorial

References (11)

1. Concern about piracetam treatment for children with Down syndrome
2. Piracetam therapy does not enhance cognitive functioning in children with Down syndrome
3. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder
4. Secretin treatment for autism
5. Review of community-based research: Assessing partnership approaches to improve public health
6. Participatory research maximises community and lay involvement: North American Primary Care Research Group
7. Principles of practice for academic/practice/community research partnerships
8. Effects of diets high in sucrose or aspartame on the behavior and cognitive performance of children
9. Megavitamins for minimal brain dysfunction: A placebo-controlled study
10. Effects of megavitamin therapy on children with attention deficit disorders
11. Hyperbaric oxygen therapy for cerebral palsy: Two complications of treatment